Table 1 The background of the enrolled patients
Characteristics | N = 53 |
Age (years) | 61.1 ± 9.8a |
Male, n (%) | 27 (50.9)b |
Body mass index (kg/m2) n = 52 | 24.8 ± 4.5 |
Abdominal girth (cm) n = 48 | 88.7 ± 9.4 |
Systolic blood pressure (mmHg) n = 52 | 127.9 ± 12.0 |
Diastolic blood pressure (mmHg) n = 52 | 73.3 ± 9.2 |
HbA1c (%) | 7.1 ± 0.8 |
Complications | |
Type 2 diabetes, n (%) | 53 (100.0)b |
 diabetic neuropathy, n (%) | 10 (18.9) |
 diabetic nephropathy, n (%) | 5 (9.4) |
 diabetic retinopathy, n (%) | 4 (7.5) |
Hypertension, n (%) | 23 (43.4) |
Coronary artery disease, n (%) | 4 (7.5) |
Cerebral artery disease, n (%) | 1 (1.9) |
Peripheral artery disease, n (%) | 2 (3.8) |
Concurrent medications | |
Anti-diabetic agents | Â |
 sulfonyl urea | 28 (52.8)b |
 biguanide | 25 (47.2) |
 α-glucosidase inhibitor | 23 (43.4) |
 pioglitazone | 10 (18.9) |
 Insulin | 5 (9.4) |
Anti-hypertensive agents | Â |
 angiotensin II type 1 receptor blockers (ARBs) | 18 (34.0)b |
 calcium channel blockers | 13 (24.5) |
 diuretics | 7 (13.2) |
 angiotensin-converting enzyme inhibitors | 5 (9.4) |
Anti-lipidemic agents | Â |
 fenofibrate | 2 (3.8)b |